As of 2025-11-13, the Relative Valuation of Oxford BioMedica PLC (OXB.L) is (264.41) GBP. This relative valuation is based on P/E multiples. With the latest stock price at 614.00 GBP, the upside of Oxford BioMedica PLC based on Relative Valuation is -143.1%.
The range of the Relative Valuation is (226.64) - (291.73) GBP.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 7.2x - 10.3x | 8.6x |
| Forward P/E multiples | 7.8x - 10.0x | 9.6x |
| Fair Price | (226.64) - (291.73) | (264.41) |
| Upside | -136.9% - -147.5% | -143.1% |
| Date | P/E |
| 2025-11-11 | -21.27 |
| 2025-11-10 | -21.17 |
| 2025-11-07 | -21.72 |
| 2025-11-06 | -21.96 |
| 2025-11-05 | -22.71 |
| 2025-11-04 | -23.40 |
| 2025-11-03 | -22.40 |
| 2025-10-31 | -22.73 |
| 2025-10-30 | -22.61 |
| 2025-10-29 | -22.54 |
| 2025-10-28 | -22.09 |
| 2025-10-27 | -21.30 |
| 2025-10-24 | -20.96 |
| 2025-10-23 | -20.62 |
| 2025-10-22 | -19.82 |
| 2025-10-21 | -19.79 |
| 2025-10-20 | -19.82 |
| 2025-10-17 | -20.24 |
| 2025-10-16 | -21.27 |
| 2025-10-15 | -21.10 |
| 2025-10-14 | -21.44 |
| 2025-10-13 | -22.30 |
| 2025-10-10 | -22.16 |
| 2025-10-09 | -22.34 |
| 2025-10-08 | -22.30 |
| 2025-10-07 | -21.44 |
| 2025-10-06 | -21.68 |
| 2025-10-03 | -21.17 |
| 2025-10-02 | -20.37 |
| 2025-10-01 | -20.34 |
| 2025-09-30 | -19.27 |
| 2025-09-29 | -19.20 |
| 2025-09-26 | -18.62 |
| 2025-09-25 | -19.89 |
| 2025-09-24 | -20.10 |
| 2025-09-23 | -20.27 |
| 2025-09-22 | -21.65 |
| 2025-09-19 | -20.17 |
| 2025-09-18 | -19.86 |
| 2025-09-17 | -20.24 |
| 2025-09-16 | -20.13 |
| 2025-09-15 | -20.55 |
| 2025-09-12 | -19.89 |
| 2025-09-11 | -20.75 |
| 2025-09-10 | -20.82 |
| 2025-09-09 | -20.48 |
| 2025-09-08 | -20.27 |
| 2025-09-05 | -20.27 |
| 2025-09-04 | -19.69 |
| 2025-09-03 | -19.65 |